LGT Capital Partners LTD. Has $21.03 Million Stake in UnitedHealth Group Incorporated (NYSE:UNH)

LGT Capital Partners LTD. lowered its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 28.3% during the first quarter, HoldingsChannel.com reports. The institutional investor owned 40,147 shares of the healthcare conglomerate’s stock after selling 15,883 shares during the period. LGT Capital Partners LTD.’s holdings in UnitedHealth Group were worth $21,027,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Citizens National Bank Trust Department grew its holdings in UnitedHealth Group by 1.0% in the 1st quarter. Citizens National Bank Trust Department now owns 17,886 shares of the healthcare conglomerate’s stock valued at $9,368,000 after buying an additional 170 shares during the last quarter. Fort Washington Investment Advisors Inc. OH grew its holdings in shares of UnitedHealth Group by 0.3% during the 1st quarter. Fort Washington Investment Advisors Inc. OH now owns 530,103 shares of the healthcare conglomerate’s stock worth $277,641,000 after purchasing an additional 1,465 shares in the last quarter. Sherbrooke Park Advisers LLC acquired a new stake in shares of UnitedHealth Group during the 4th quarter worth approximately $515,000. Full Sail Capital LLC grew its holdings in shares of UnitedHealth Group by 2.1% during the 4th quarter. Full Sail Capital LLC now owns 1,612 shares of the healthcare conglomerate’s stock worth $815,000 after purchasing an additional 33 shares in the last quarter. Finally, Soros Fund Management LLC acquired a new stake in shares of UnitedHealth Group during the 4th quarter worth approximately $39,413,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, Director Kristen Gil purchased 3,700 shares of the company’s stock in a transaction dated Thursday, May 15th. The shares were bought at an average price of $271.17 per share, with a total value of $1,003,329.00. Following the completion of the transaction, the director directly owned 3,818 shares in the company, valued at $1,035,327.06. This trade represents a 3,135.59% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Timothy Patrick Flynn purchased 1,533 shares of the company’s stock in a transaction dated Wednesday, May 14th. The shares were acquired at an average cost of $320.80 per share, for a total transaction of $491,786.40. Following the transaction, the director owned 6,033 shares of the company’s stock, valued at $1,935,386.40. This trade represents a 34.07% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have acquired a total of 109,408 shares of company stock valued at $31,607,768 over the last 90 days. Insiders own 0.28% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have recently weighed in on the company. Piper Sandler decreased their price objective on UnitedHealth Group from $353.00 to $317.00 and set an “overweight” rating on the stock in a report on Wednesday. Raymond James Financial cut UnitedHealth Group from a “strong-buy” rating to a “market perform” rating in a research report on Wednesday, May 14th. Deutsche Bank Aktiengesellschaft lowered their price target on UnitedHealth Group from $521.00 to $362.00 and set a “buy” rating on the stock in a research report on Wednesday, May 14th. Barclays reiterated an “overweight” rating on shares of UnitedHealth Group in a research report on Thursday, July 17th. Finally, Argus cut UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Monday, April 21st. Three investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and fifteen have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $373.52.

UnitedHealth Group Trading Down 4.9%

Shares of UNH opened at $237.40 on Friday. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. UnitedHealth Group Incorporated has a 12-month low of $234.60 and a 12-month high of $630.73. The firm has a market capitalization of $215.36 billion, a PE ratio of 10.29, a price-to-earnings-growth ratio of 1.49 and a beta of 0.43. The stock’s fifty day simple moving average is $296.86 and its 200-day simple moving average is $415.36.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The company had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. During the same period in the previous year, the company posted $6.80 EPS. The company’s quarterly revenue was up 12.9% compared to the same quarter last year. As a group, research analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th were given a dividend of $2.21 per share. This is an increase from UnitedHealth Group’s previous quarterly dividend of $2.10. This represents a $8.84 dividend on an annualized basis and a dividend yield of 3.7%. The ex-dividend date of this dividend was Monday, June 16th. UnitedHealth Group’s payout ratio is 38.30%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.